Loading company…
MitoKor developed drugs for diseases associated with mitochondrial dysfunction.
Founded in 1991 and based in California, MitoKor developed and commercialized drugs for conditions associated with mitochondrial dysfunction, including type two diabetes, Parkinson's disease, and Alzheimer's disease.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in